The purpose of the study was to evaluate the duration of inhibition of acid secretion by single oral doses of cimetidine and ranitidine. Basal and postprandial acid secretion in 6 healthy volunteers were measured for 14 h by intermittent aspiration and prolonged intragastric titration. 400 mg cimetidine reduced daytime acid secretion by 22% and 150 mg ranitidine produced 38% inhibition. Although the elimination half lives of the drugs were similar, ranitidine led to more pronounced inhibition of acid secretion during the later part of the day. The longer duration of pronounced acid inhibition by ranitidine appears to be due solely to its greater potency.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Brogden RN, Carmine AA, Heel RC, Speight TM, Avery GS (1982) Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs 24: 267–303
Walt RP, Trotman IF, Frost R, Golding PL, Shepherd TH, Rowlings J, Hunt RH, Colin-Jones D, Milton-Thompson GJ, Misiewicz JJ (1981) Comparison of twice daily ranitidine with standard cimetidine treatment of duodenal ulcer. Gut 22: 319–322
Dammann HG, Simon B (1981) The new H2-receptor antagonist ranitidine. Duration of action. Scand J Gastroenterol 16 suppl 69: 39–41
Langman MJS, Henry DA, Ogilvie A (1981) Ranitidine and cimetidine for duodenal ulcer. Scand J Gastroenterol 16 suppl 69: 115–116
Peden NR, Boyd EJS, Saunders JHB, Wormsley KG (1981) Ranitidine in the treatment of duodenal ulceration. Scand J Gastroenterol 16 [Suppl 69]: 325–329
Barr GD, Paris CH, Middleton WRJ, Piper DW (1982) Comparison of ranitidine with cimetidine in duodenal ulcer healing. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation Series 5, Oxford, pp 146–151
Lishman AH, Record CO (1982) Ranitidine in the management of duodenal ulceration: controlled and open comparison with cimetidine. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation Series 5, Oxford, pp 161–165
van Dommelen CKV, Stadler FH, Boekhorst JC (1982) Comparison of ranitidine with cimetidine in the treatment of duodenal ulcer. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation Series 5, Oxford, pp 152–154
Quina M (1982) Clinical trial of ranitidine in duodenal ulcer in Portugal. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation Series 5, Oxford, pp 176–177
Zeitoun P, d'Azemar P (1982) International multicentre clinical trial of ranitidine in duodenal ulcer. Comparison with cimetidine. In: Misiewicz JJ, Wormsley KG (eds) The clinical use of ranitidine. Medicine Publishing Foundation Series 5, Oxford, pp 141–145
Eckardt V (1982) Cimetidine: twice daily administration in duodenal ulcer — results of a European multicentre study. In: Baron JH (ed) Cimetidine in the 80s. Churchill Livingstone, Edinburgh 1981, pp 14–20
Fordtran JS, Walsh JH (1973) Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest 52: 645–657
Randolph WC, Osborne VL, Walkenstein SS, Intoccia AP (1977) Highpressure liquid chromatographic analysis of cimetidine, a histamine H2-receptor antagonist, in blood and urine. J Pharm Sci 66: 1148–1150
Carey PF, Martin LE, Owen PE (1981) Determination of ranitidine and its metabolites in human urine by reversed-phase ion-pair high-performance liquid chromatography. J Chromatogr Biomed Appl 225: 161–168
Yalow RS, Berson SA (1970) Radioimmunoassay of gastrin. Gastroenterol 58: 161–168
Corinaldesi R, Bocci G, Galassi A, Sacco T, Giacomoni E, Patrico C, Barbara L (1982) Comparison between ranitidine and cimetidine on 24 h intragastric acidity in duodenal ulcer patients. In: Abstract Book ‘The World Congresses in Stockholm Sweden’, p 98
Burland WL, Brunet PL, Hunt RH, Melvin MA, Mills JG, Vincent D, Milton-Thompson GJ (1980) Comparison of the effects on 24 h intragastric acidity of SK&F 92994 and two dose regimens of cimetidine. Hepatogastroenterology [Suppl] (International Congress of Gastroenterology) p 259
Fimmel CF, Pace F, Blum AL (1982) Wie wirksam sind H2-Blocker? Z Gastroenterologie 20: 528
Dammann HG, Hoelzer P, Friedl W, Müller P, Simon B (1983) Gastrales Säureprofil über 24 Stunden. Zweimal 400 mg Cimetidin versus zweimal 150 mg Ranitidin. Dtsch Med Wochenschr 108: 600–601
Brater DC, Peters MN, Eshelman FN, Richardson CT (1982) Clinical comparison of cimetidine and ranitidine. Clin Pharmacol Ther 32: 484–489
Gugler R, Brand M, Somogyi A (1981) Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol 20: 225–228
Longstreth GF, Go VLW, Malagelada J-R (1976) Cimetidine suppression of nocturnal acid secretion in active duodenal ulcer. N Engl J Med 294: 801–804
Kaojarern S, Feldman M, Richardson CT, Brater DC (1981) Tiotidine and cimetidine — kinetics and dynamics. Clin Pharmacol Ther 29: 198–202
Freston JW (1982) Cimetidine. II. Adverse reactions and patterns of use. Ann Intern Med 97: 728–734
About this article
Cite this article
Eckardt, V.F., Cordes, I., Janisch, H.D. et al. Daytime acid secretion after a single dose of ranitidine and cimetidine — a double blind crossover study. Eur J Clin Pharmacol 26, 177–182 (1984). https://doi.org/10.1007/BF00630283
- gastric acid secretion
- serum gastrin